Document Detail


Improved ventricular function during inhalation of PGI(2) aerosol partly relies on enhanced myocardial contractility.
MedLine Citation:
PMID:  15818036     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Inhaled prostacyclin (PGI(2)) aerosol induces selective pulmonary vasodilation. Further, it improves right ventricular (RV) function, which may largely rely on pulmonary vasodilation, but also on enhanced myocardial contractility. We investigated the effects of the inhaled PGI(2) analogs epoprostenol (EPO) and iloprost (ILO) on RV function and myocardial contractility in 9 anesthetized pigs receiving aerosolized EPO (25 and 50 ng.kg(-1).min(-1)) and, consecutively, ILO (60 ng.kg(-1).min(-1)) for 20 min each. We measured pulmonary artery pressure (PAP), RV ejection fraction (RVEF) and RV end-diastolic-volume (RV-EDV), and left ventricular end-systolic pressure-volume-relation (end-systolic elastance, E(es)). EPO and ILO reduced PAP, increased RVEF and reduced RVEDV. E(es) was enhanced during all doses tested, which reached statistical significance during EPO(25 ng) and ILO, but not during EPO(50 ng). PGI(2) aerosol enhances myocardial contractility in healthy pigs, contributing to improve RV function.
Authors:
G Kemming; H Kisch-Wedel; M Flondor; C Hofstetter; W Kreyling; E Thein; F Meisner; S Bruhn; B Zwissler
Related Documents :
6413366 - The failing heart and the circulation.
23523456 - Analysis of stroke occurring in the syntax (synergy between percutaneous coronary inter...
23153406 - Antithrombotic therapy for stroke prevention in non-valvular atrial fibrillation.
168986 - Interaction between cyclic adenosine monophosphate and cyclic gunaosine monophosphate i...
12587806 - Angiotensin ii receptor blockers in heart failure.
20524446 - Medical complications during inpatient stroke rehabilitation in thailand: a prospective...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  European surgical research. Europäische chirurgische Forschung. Recherches chirurgicales européennes     Volume:  37     ISSN:  0014-312X     ISO Abbreviation:  Eur Surg Res     Publication Date:    2005 Jan-Feb
Date Detail:
Created Date:  2005-04-08     Completed Date:  2005-07-12     Revised Date:  2006-11-30    
Medline Journal Info:
Nlm Unique ID:  0174752     Medline TA:  Eur Surg Res     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  9-17     Citation Subset:  IM    
Affiliation:
Institute for Surgical Research, Ludwig-Maximilians-University, Munich, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Administration, Inhalation
Aerosols
Animals
Blood Pressure / drug effects
Blood Volume / drug effects
Dose-Response Relationship, Drug
Drug Administration Schedule
Epoprostenol / administration & dosage*,  pharmacology
Iloprost / administration & dosage*,  pharmacology
Myocardial Contraction / drug effects*
Stroke Volume / drug effects
Swine
Vasodilator Agents / administration & dosage*,  pharmacology
Ventricular Function, Right / drug effects*
Chemical
Reg. No./Substance:
0/Aerosols; 0/Vasodilator Agents; 35121-78-9/Epoprostenol; 78919-13-8/Iloprost

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Hemoglobin-based oxygen carrier distribution inside vascular wall and arterial pressure evolution: i...
Next Document:  Thoracoscopic decortication: first-line therapy for pediatric empyema.